Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 391
5
Diseases
66
Unique genes
0.212
Avg. similarity score
Calcinosis
Most-connected disease (4 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Calcinosis
Heart valve disease
Heart valve prolapse
Vitamin k deficiency
Hereditary arterial and articular multiple calcification syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Calcinosis | 4 | 4 | 46 |
| Heart valve disease | 3 | 3 | 41 |
| Heart valve prolapse | 3 | 3 | 29 |
| Vitamin k deficiency | 3 | 3 | 1 |
| Hereditary arterial and articular multiple calcification syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| BGLAP | 4 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse, Vitamin k deficiency |
| C6 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| CASP3 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| CCL2 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| COL18A1 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| COL1A1 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| FCGR1A | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| IL18 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| IL1B | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| ITGB2 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| JAK2 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| LCN2 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| LSP1 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| LY86 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| NOTCH1 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| PTPN6 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| PYCARD | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| RIPK3 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| SPN | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| SPP1 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| TIMP1 | 3 / 5 | Calcinosis, Heart valve disease, Heart valve prolapse |
| ACE | 2 / 5 | Heart valve disease, Heart valve prolapse |
| ADAMTS19 | 2 / 5 | Heart valve disease, Heart valve prolapse |
| ADAMTSL2 | 2 / 5 | Heart valve disease, Heart valve prolapse |
| CCL15 | 2 / 5 | Heart valve disease, Heart valve prolapse |
| COL1A2 | 2 / 5 | Heart valve disease, Heart valve prolapse |
| FGFR1 | 2 / 5 | Heart valve disease, Heart valve prolapse |
| HTR2B | 2 / 5 | Heart valve disease, Heart valve prolapse |
| NT5E | 2 / 5 | Calcinosis, Hereditary arterial and articular multiple calcification syndrome |
| PCDHA9 | 2 / 5 | Heart valve disease, Heart valve prolapse |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Interleukin-4 and Interleukin-13 signaling | Reactome | 15 / 108 | 25.3× | 1.37e-17 | 7.24e-15 ✓ sig. |
| AGE-RAGE signaling pathway in diabetic complications | KEGG | 9 / 101 | 16.2× | 3.65e-9 | 3.56e-7 ✓ sig. |
| Leishmaniasis | KEGG | 8 / 78 | 18.7× | 9.30e-9 | 8.19e-7 ✓ sig. |
| Proteoglycans in cancer | KEGG | 11 / 204 | 9.8× | 1.23e-8 | 1.04e-6 ✓ sig. |
| Pathways in cancer | KEGG | 16 / 533 | 5.5× | 1.97e-8 | 1.59e-6 ✓ sig. |
| FGFR1c and Klotho ligand binding and activation | Reactome | 3 / 3 | 182× | 1.59e-7 | 9.76e-6 ✓ sig. |
| Malaria | KEGG | 6 / 50 | 21.8× | 2.87e-7 | 1.64e-5 ✓ sig. |
| PI3K-Akt signaling pathway | KEGG | 12 / 361 | 6.0× | 5.17e-7 | 2.75e-5 ✓ sig. |
| Legionellosis | KEGG | 6 / 56 | 19.5× | 5.72e-7 | 3.00e-5 ✓ sig. |
| Tuberculosis | KEGG | 9 / 181 | 9.0× | 5.81e-7 | 3.05e-5 ✓ sig. |
| Activation of Matrix Metalloproteinases | Reactome | 5 / 33 | 27.6× | 9.05e-7 | 4.47e-5 ✓ sig. |
| Amoebiasis | KEGG | 7 / 103 | 12.4× | 1.43e-6 | 6.66e-5 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 9 / 216 | 7.6× | 2.54e-6 | 1.08e-4 ✓ sig. |
| Melanoma | KEGG | 6 / 73 | 15.0× | 2.79e-6 | 1.17e-4 ✓ sig. |
| Pertussis | KEGG | 6 / 78 | 14.0× | 4.12e-6 | 1.62e-4 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| positive regulation of cell migration | GO:0030335 | 14 / 292 | 13.6× | 1.42e-12 | 6.31e-10 ✓ sig. |
| positive regulation of ERK1 and ERK2 cascade | GO:0070374 | 11 / 201 | 15.5× | 1.09e-10 | 3.10e-8 ✓ sig. |
| response to macrophage colony-stimulating factor | GO:0036005 | 4 / 4 | 283× | 1.42e-10 | 3.94e-8 ✓ sig. |
| response to xenobiotic stimulus | GO:0009410 | 11 / 248 | 12.6× | 1.02e-9 | 2.27e-7 ✓ sig. |
| positive regulation of apoptotic process | GO:0043065 | 12 / 326 | 10.4× | 1.38e-9 | 2.99e-7 ✓ sig. |
| skeletal system development | GO:0001501 | 9 / 151 | 16.9× | 2.89e-9 | 5.71e-7 ✓ sig. |
| positive regulation of cell population proliferation | GO:0008284 | 14 / 532 | 7.5× | 3.85e-9 | 7.41e-7 ✓ sig. |
| positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | GO:0051897 | 10 / 217 | 13.0× | 4.34e-9 | 8.20e-7 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 16 / 778 | 5.8× | 8.51e-9 | 1.49e-6 ✓ sig. |
| response to vitamin D | GO:0033280 | 5 / 21 | 67.4× | 9.17e-9 | 1.59e-6 ✓ sig. |
| positive regulation of smooth muscle cell proliferation | GO:0048661 | 6 / 52 | 32.7× | 2.76e-8 | 4.09e-6 ✓ sig. |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 5 / 34 | 41.6× | 1.21e-7 | 1.41e-5 ✓ sig. |
| smooth muscle adaptation | GO:0014805 | 3 / 4 | 212× | 1.68e-7 | 1.87e-5 ✓ sig. |
| positive regulation of gene expression | GO:0010628 | 12 / 504 | 6.7× | 1.70e-7 | 1.89e-5 ✓ sig. |
| apoptotic process | GO:0006915 | 14 / 747 | 5.3× | 2.65e-7 | 2.74e-5 ✓ sig. |
Pairs within this cluster, by significance
| Disease A ⇵ | Disease B ⇵ | Similarity score ⇵ | Shared genes ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Heart valve disease | Heart valve prolapse | 0.690 | 29 | 2.62e-81 | 2.21e-79 ✓ sig. |
| Calcinosis | Heart valve prolapse | 0.382 | 21 | 1.76e-49 | 9.67e-48 ✓ sig. |
| Calcinosis | Heart valve disease | 0.313 | 21 | 1.09e-44 | 5.36e-43 ✓ sig. |
| Heart valve prolapse | Vitamin k deficiency | 0.033 | 1 | 1.88e-3 | 2.75e-3 ✓ sig. |
| Heart valve disease | Vitamin k deficiency | 0.024 | 1 | 2.66e-3 | 3.58e-3 ✓ sig. |
| Calcinosis | Hereditary arterial and articular multiple calcification syndrome | 0.021 | 1 | 2.99e-3 | 3.94e-3 ✓ sig. |
| Calcinosis | Vitamin k deficiency | 0.021 | 1 | 2.99e-3 | 3.94e-3 ✓ sig. |